Trials / Completed
CompletedNCT02135679
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CTC levels collected pre-surgery will be correlated with pathological samples.
Detailed description
Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will collect demographic and treatment data and explore \& describe the pattern of CTC detection in all patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2019-12-01
- Completion
- 2021-12-01
- First posted
- 2014-05-12
- Last updated
- 2024-11-20
- Results posted
- 2024-10-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02135679. Inclusion in this directory is not an endorsement.